IMI-PainCare

Improving the care of patients suffering from acute or chronic pain
IMI-PainCare logo

FACTS & FIGURES

Start Date
End Date
Call
IMI2 - Call 10
Grant agreement number
777500

Type of Action: 
RIA (Research and Innovation Action)

Contributions
IMI Funding
11 225 271
EFPIA in kind
12 030 000
Other
100 500
Total Cost
23 355 771

Summary

Patients with a wide range of conditions may experience pain in the short or long term, and all too often, painkillers prove ineffective. Developing new analgesics is extremely challenging, and all too often, promising results in the lab do not translate into effective treatments for patients. The goal of IMI-PainCare is to develop a toolbox that will aid in the development of novel painkillers. The project comprises three sub-projects, which between them address all stages of drug development, from early-stage research to clinical practice.

PROMPT aims to develop patient-reported outcomes that will capture in a standardised way patients’ perceptions of their pain. This information will help to show during clinical trials whether or not a treatment is actually effective at alleviating pain, for example.

BioPain will draw on elecrophysiological and imaging technologies to establish models of pain in healthy humans and rodents. This will contribute to the development of markers of pain that are relevant in both rodents and humans; this will increase researchers’ chances of translating findings in the lab into new treatments for patients.

TRiPP focuses on pelvic pain caused by endometriosis and interstitial cystitis / bladder pain syndrome. The team hopes to identify different subgroups of patients; information that will help to deliver more personalised treatments for these debilitating conditions.

The IMI-PainCare consortium plans to work with regulators to validate the tools developed.

Participants Show participants on map

EFPIA companies
  • Bayer Aktiengesellschaft, Leverkusen, Germany
  • Eli Lilly and Company Limited, Basingstoke, United Kingdom
  • Esteve Pharmaceuticals, SA, Barcelona, Spain
  • Gruenenthal GMBH, Aachen, Germany
  • Novartis Pharma AG, Basel, Switzerland
  • Teva Pharmaceutical Industries Limited, Netanya, Israel
Universities, research organisations, public bodies, non-profit groups
  • Aalborg Universitet, Aalborg OE, Denmark
  • Aarhus Universitet, Aarhus C, Denmark
  • Assistance Publique - Hopitaux De Paris, Paris, France
  • Children'S Hospital Corporation, Boston, United States
  • Christian-Albrechts-Universitaet Zu Kiel, Kiel, Germany
  • Cliniques Universitaires Saint-Luc, Brussels, Belgium
  • European Pain Federation Efic, Aarschot, Belgium
  • European Society Of Anaesthesiology Aisbl, Bruxelles, Belgium
  • European Society Of Regional Anaesthesia And Pain Therapy, Homberg, Germany
  • Fundacion Para La Investigacion Del Hospital Clinico De La Comunitat Valenciana, Fundacion Incliva, Valencia, Spain
  • Helsingin Ja Uudenmaan Sairaanhoitopiirin Kuntayhtymä, Helsinki, Finland
  • Institut National De La Sante Et De La Recherche Medicale, Paris, France
  • Instituto De Biologia Molecular E Celular-Ibmc, Porto, Portugal
  • King'S College London, London, United Kingdom
  • Michigan State University, East Lansing, Michigan, United States
  • Queen Mary University Of London, London, United Kingdom
  • Region Hovedstaden, Hilleroed, Denmark
  • Ruprecht-Karls-Universitaet Heidelberg, Heidelberg, Germany
  • The University Of Edinburgh, Edinburgh, United Kingdom
  • Universidad De Navarra, Pamplona, Spain
  • Universita Degli Studi Di Roma La Sapienza, Roma, Italy
  • Universite Catholique De Louvain, Louvain-La-Neuve, Belgium
  • University College Cork - National University Of Ireland, Cork, Cork, Ireland
  • University of Oxford, Oxford, United Kingdom
  • Universitätsklinikum Jena, Jena, Germany
  • Westfaelische Wilhelms-Universitaet Muenster, Münster, Germany
Small and medium-sized enterprises (SMEs) and mid-sized companies (<€500 m turnover)
  • Actual Analytics LTD, Edinburgh, United Kingdom
  • Consultech Technologieberatung GMBH, Berlin, Germany
  • Mrc Systems GMBH Medizintechnische Systeme, Heidelberg, Germany
  • Neuroscience Technologies Slp, Barcelona, Spain
  • Promptly - Software Solutions For Health Measures, Lda, Porto, Portugal
Patient organisations
  • Endometriosis.Org LTD, London, United Kingdom
  • Pelvic Pain Support Network, Poole, United Kingdom
  • Stichting International Painful Bladder Foundation, Naarden, Netherlands

CONTACT

Project coordinator
Rolf-Detlef TREEDE
RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG
rolf-detlef.treede[at]medma.uni-heidelberg.de
Project leader
Petra BLOMS-FUNKE
Gruenenthal GMBH
Sub-project coordinator
Winfried MEISSNER
Universitätsklinikum Jena
Sub-project coordinator
Katy VINCENT
University of Oxford
Project leader
Hiltrud LIEDGENS
GRÜNENTHAL
Hiltrud.Liedgens[at]grunenthal.com
Project leader
Geoffrey PHILLIPS
LILLY
phillips_keith_geoffrey[at]lilly.com
Project leader
Jens NAGEL
BAYER
jens.nagel[at]bayer.com